These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 28266127)

  • 1. Mitochondrial PKC-ε deficiency promotes I/R-mediated myocardial injury via GSK3β-dependent mitochondrial permeability transition pore opening.
    Wang S; Zhang F; Zhao G; Cheng Y; Wu T; Wu B; Zhang YE
    J Cell Mol Med; 2017 Sep; 21(9):2009-2021. PubMed ID: 28266127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion.
    Gomez L; Paillard M; Thibault H; Derumeaux G; Ovize M
    Circulation; 2008 May; 117(21):2761-8. PubMed ID: 18490522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore.
    Ananthakrishnan R; Kaneko M; Hwang YC; Quadri N; Gomez T; Li Q; Caspersen C; Ramasamy R
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H333-41. PubMed ID: 19060123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldehyde dehydrogenase 2 knockout accentuates ethanol-induced cardiac depression: role of protein phosphatases.
    Ma H; Yu L; Byra EA; Hu N; Kitagawa K; Nakayama KI; Kawamoto T; Ren J
    J Mol Cell Cardiol; 2010 Aug; 49(2):322-9. PubMed ID: 20362583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress.
    Townsend PA; Davidson SM; Clarke SJ; Khaliulin I; Carroll CJ; Scarabelli TM; Knight RA; Stephanou A; Latchman DS; Halestrap AP
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H928-38. PubMed ID: 17483234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore.
    Xi J; Wang H; Mueller RA; Norfleet EA; Xu Z
    Eur J Pharmacol; 2009 Feb; 604(1-3):111-6. PubMed ID: 19135050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local delivery of PKCepsilon-activating peptide mimics ischemic preconditioning in aged hearts through GSK-3beta but not F1-ATPase inactivation.
    Korzick DH; Kostyak JC; Hunter JC; Saupe KW
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2056-63. PubMed ID: 17675573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta.
    Park SS; Zhao H; Jang Y; Mueller RA; Xu Z
    J Pharmacol Exp Ther; 2006 Jul; 318(1):124-31. PubMed ID: 16611852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anesthetic-induced preconditioning delays opening of mitochondrial permeability transition pore via protein Kinase C-epsilon-mediated pathway.
    Pravdic D; Sedlic F; Mio Y; Vladic N; Bienengraeber M; Bosnjak ZJ
    Anesthesiology; 2009 Aug; 111(2):267-74. PubMed ID: 19568162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore.
    Obame FN; Plin-Mercier C; Assaly R; Zini R; Dubois-Randé JL; Berdeaux A; Morin D
    J Pharmacol Exp Ther; 2008 Jul; 326(1):252-8. PubMed ID: 18434587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.
    Mozaffari MS; Schaffer SW
    Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection.
    Nishihara M; Miura T; Miki T; Tanno M; Yano T; Naitoh K; Ohori K; Hotta H; Terashima Y; Shimamoto K
    J Mol Cell Cardiol; 2007 Nov; 43(5):564-70. PubMed ID: 17931653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSK-3beta, a therapeutic target for cardiomyocyte protection.
    Miura T; Miki T
    Circ J; 2009 Jul; 73(7):1184-92. PubMed ID: 19506320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temperature preconditioning of isolated rat hearts--a potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore.
    Khaliulin I; Clarke SJ; Lin H; Parker J; Suleiman MS; Halestrap AP
    J Physiol; 2007 Jun; 581(Pt 3):1147-61. PubMed ID: 17395631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation.
    Clarke SJ; Khaliulin I; Das M; Parker JE; Heesom KJ; Halestrap AP
    Circ Res; 2008 May; 102(9):1082-90. PubMed ID: 18356542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute PKCdelta inhibition limits ischaemia-reperfusion injury in the aged rat heart: role of GSK-3beta.
    Kostyak JC; Hunter JC; Korzick DH
    Cardiovasc Res; 2006 May; 70(2):325-34. PubMed ID: 16542646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3beta.
    Chanoit G; Lee S; Xi J; Zhu M; McIntosh RA; Mueller RA; Norfleet EA; Xu Z
    Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1227-H1233. PubMed ID: 18660440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
    Liu YN; Zhou ZM; Chen P
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: role of GSK-3beta in myocardial protection against ischemia/reperfusion injury.
    Miura T; Nishihara M; Miki T
    J Pharmacol Sci; 2009 Feb; 109(2):162-7. PubMed ID: 19179805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial aldehyde dehydrogenase rescues against diabetic cardiomyopathy through GSK3β-mediated preservation of mitochondrial integrity and Parkin-mediated mitophagy.
    Zhang Y; Zou R; Abudureyimu M; Liu Q; Ma J; Xu H; Yu W; Yang J; Jia J; Qian S; Wang H; Yang Y; Wang X; Fan X; Ren J
    J Mol Cell Biol; 2024 Apr; 15(9):. PubMed ID: 37771085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.